Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014.

Sherrard J, Ison C, Moody J, Wainwright E, Wilson J, Sullivan A.

Int J STD AIDS. 2014 Jul;25(8):541-9. doi: 10.1177/0956462414525947. Epub 2014 Mar 10.

PMID:
24616117
2.

Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.

Seña AC, Bachmann LH, Hobbs MM.

Expert Rev Anti Infect Ther. 2014 Jun;12(6):673-85. doi: 10.1586/14787210.2014.887440. Epub 2014 Feb 20. Review.

PMID:
24555561
3.

Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.

Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR.

Clin Infect Dis. 2014 Sep 15;59(6):834-41. doi: 10.1093/cid/ciu446. Epub 2014 Jun 13.

PMID:
24928292
4.

Trichomoniasis in teens: an update.

Huppert JS.

Curr Opin Obstet Gynecol. 2009 Oct;21(5):371-8. doi: 10.1097/GCO.0b013e32832e0827. Review.

PMID:
19491679
5.

A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Meites E, Gaydos CA, Hobbs MM, Kissinger P, Nyirjesy P, Schwebke JR, Secor WE, Sobel JD, Workowski KA.

Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S837-48. doi: 10.1093/cid/civ738. Review.

6.

Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.

Meites E, Llata E, Braxton J, Schwebke JR, Bernstein KT, Pathela P, Asbel LE, Kerani RP, Mettenbrink CJ, Weinstock HS.

Sex Transm Dis. 2013 Nov;40(11):865-9. doi: 10.1097/OLQ.0000000000000038.

7.

Trichomonas vaginalis Infection in a Tertiary Care Vaginitis Center.

Keating MA, Nyirjesy P.

Sex Transm Dis. 2015 Sep;42(9):482-5. doi: 10.1097/OLQ.0000000000000334.

PMID:
26267873
8.

Trichomonas vaginalis: an audit of clinical practice and the demography of infected patients at three London genitourinary medicine clinics.

Tittle V, Bull L, Boag F.

Int J STD AIDS. 2013 Nov;24(11):902-4. doi: 10.1177/0956462413486460. Epub 2013 Jul 19.

PMID:
23970607
9.

Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.

Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM.

Clin Infect Dis. 2002 Sep 1;35(5):576-80. Epub 2002 Aug 6.

PMID:
12173132
10.

Trichomoniasis: the "neglected" sexually transmitted disease.

Meites E.

Infect Dis Clin North Am. 2013 Dec;27(4):755-64. doi: 10.1016/j.idc.2013.06.003. Epub 2013 Oct 25. Review.

11.

Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.

Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, Atashili J, Cohen MS.

Clin Infect Dis. 2007 Jan 1;44(1):13-22. Epub 2006 Nov 27.

PMID:
17143809
12.

Trichomonas vaginalis in a Sheffield genitourinary medicine department.

Woodland H, Rogstad KE.

Int J STD AIDS. 2005 Jul;16(7):491-3.

PMID:
16004629
13.

Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report.

Tayal S.

Int J STD AIDS. 2016 Feb;27(2):147-8. doi: 10.1177/0956462415580513. Epub 2015 Mar 30.

PMID:
25829518
14.

[Therapeutic aspects of trichomoniasis].

Vukićević J, Jankicević J.

Srp Arh Celok Lek. 2003 Mar-Apr;131(3-4):156-61. Serbian.

15.

Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea.

Kim SR, Kim JH, Gu NY, Kim YS, Hong YC, Ryu JS.

Korean J Parasitol. 2016 Apr;54(2):187-90. doi: 10.3347/kjp.2016.54.2.187. Epub 2016 Apr 30.

16.

Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.

Roth AM, Williams JA, Ly R, Curd K, Brooks D, Arno J, Van Der Pol B.

Sex Transm Dis. 2011 May;38(5):398-400. doi: 10.1097/OLQ.0b013e318203e3ce.

PMID:
21217417
17.

Prevention or treatment: the benefits of Trichomonas vaginalis vaccine.

Cudmore SL, Garber GE.

J Infect Public Health. 2010;3(2):47-53. doi: 10.1016/j.jiph.2010.01.003. Epub 2010 May 15. Review.

18.

Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission.

Lazenby GB, Unal ER, Andrews AL, Simpson K.

Sex Transm Dis. 2014 Jun;41(6):353-8. doi: 10.1097/OLQ.0000000000000008.

PMID:
24827616
19.

Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.

Van der Pol B.

Clin Infect Dis. 2007 Jan 1;44(1):23-5. Epub 2006 Nov 27. Review. No abstract available.

PMID:
17143810
20.

Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation.

Swygard H, Miller WC, Kaydos-Daniels SC, Cohen MS, Leone PA, Hobbs MM, Seña AC.

Sex Transm Dis. 2004 Nov;31(11):659-64.

PMID:
15502673

Supplemental Content

Support Center